Singapore manufacturing contracts in July, again
The disconnect between Singapore's exports and manufacturing growth persists in July, though underlying trends in both remain mildly positive. Even so, we see nothing on the horizon to turn the negative GDP trend around just yet
8.4% |
July manufacturing fallYear-on-year |
Worse than expected |
Pharma dents manufacturing
Singapore's July industrial production contracted by 8.4% year-on-year but was up 1.6% month-on-month (seasonally adjusted). The outcome was slightly weaker than consensus median estimates of -7.0% YoY and +3.7% MoM seasonally adjusted.
In July, pharmaceuticals were a weak spot with a 39% MoM and 31% YoY plunge while electronics saw a 24% MoM surge (-1.4% YoY) making up for the pharma weakness. Chemicals including petrochemicals also posted month-on-month gains but were down on a year-on-year basis.
Export-manufacturing disconnect
This was the third consecutive month that the year-on-year fall in industrial production contrasted with growth in non-oil domestic exports on the same basis. NODX was up 6% YoY in July.
The industrial production and NODX disconnect is largely explained by the base year effect, which has been favourable for NODX but not so much for IP lately. But the underlying trends in both have been mildly positive, thanks to disproportionate benefits from a surge in pharmaceuticals demand during the pandemic.
Despite weakness in July, year-to-date pharma exports are up 28% and production is up 27%. Another key driver, electronics, has also eked out some gains – exports are up 3.8% and production is almost flat (-0.6%). This brings the year-to-date growths in total NODX and IP of 5.7% and 1.6%, respectively.
Year-to-date exports and production performance
Continued GDP contraction
The surprising resilience of exports and manufacturing persists in 3Q, however, that won't be enough to come back from the 13% YoY GDP contraction recorded in 2Q. We see exceptionally weak construction and service sector activity keeping GDP growth deep in the negative territory. Our forecast for GDP growth in 3Q is -8.2% and that for the full-year 2020 is -6.9%.
There is nothing more expected on the macro policy front to turn this negative trend around over the remainder of the year. The next key policy event is the central bank's semi-annual policy review in October. We anticipate no change from the current policy stance of zero appreciation of Singapore Dollar Nominal Effective Exchange Rate (S$-NEER).
Tags
Singapore economyDownload
Download article27 August 2020
Good MornING Asia - 27 August 2020 This bundle contains 3 articles"THINK Outside" is a collection of specially commissioned content from third-party sources, such as economic think-tanks and academic institutions, that ING deems reliable and from non-research departments within ING. ING Bank N.V. ("ING") uses these sources to expand the range of opinions you can find on the THINK website. Some of these sources are not the property of or managed by ING, and therefore ING cannot always guarantee the correctness, completeness, actuality and quality of such sources, nor the availability at any given time of the data and information provided, and ING cannot accept any liability in this respect, insofar as this is permissible pursuant to the applicable laws and regulations.
This publication does not necessarily reflect the ING house view. This publication has been prepared solely for information purposes without regard to any particular user's investment objectives, financial situation, or means. The information in the publication is not an investment recommendation and it is not investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument. Reasonable care has been taken to ensure that this publication is not untrue or misleading when published, but ING does not represent that it is accurate or complete. ING does not accept any liability for any direct, indirect or consequential loss arising from any use of this publication. Unless otherwise stated, any views, forecasts, or estimates are solely those of the author(s), as of the date of the publication and are subject to change without notice.
The distribution of this publication may be restricted by law or regulation in different jurisdictions and persons into whose possession this publication comes should inform themselves about, and observe, such restrictions.
Copyright and database rights protection exists in this report and it may not be reproduced, distributed or published by any person for any purpose without the prior express consent of ING. All rights are reserved.
ING Bank N.V. is authorised by the Dutch Central Bank and supervised by the European Central Bank (ECB), the Dutch Central Bank (DNB) and the Dutch Authority for the Financial Markets (AFM). ING Bank N.V. is incorporated in the Netherlands (Trade Register no. 33031431 Amsterdam).